$SKIN
Beauty Health Co

2024 Q4 Form 10-Q Financial Statement

#000162828024047310 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $78.80M
YoY Change -19.11%
Cost Of Revenue $38.15M
YoY Change -65.3%
Gross Profit $40.65M
YoY Change -423.82%
Gross Profit Margin 51.58%
Selling, General & Admin $61.06M
YoY Change -9.83%
% of Gross Profit 150.2%
Research & Development $1.108M
YoY Change -39.75%
% of Gross Profit 2.73%
Depreciation & Amortization $8.114M
YoY Change 10.39%
% of Gross Profit 19.96%
Operating Expenses $62.16M
YoY Change -10.62%
Operating Profit -$21.52M
YoY Change -73.79%
Interest Expense $4.685M
YoY Change 35.99%
% of Operating Profit
Other Income/Expense, Net $69.00K
YoY Change -98.58%
Pretax Income -$16.34M
YoY Change -76.77%
Income Tax $1.948M
% Of Pretax Income
Net Earnings -$18.29M
YoY Change -75.22%
Net Earnings / Revenue -23.21%
Basic Earnings Per Share -$0.15
Diluted Earnings Per Share -$0.15
COMMON SHARES
Basic Shares Outstanding 124.1M shares 124.0M shares
Diluted Shares Outstanding 124.1M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $358.9M
YoY Change -35.84%
Cash & Equivalents $358.9M
Short-Term Investments
Other Short-Term Assets $16.03M
YoY Change -55.34%
Inventory $73.44M
Prepaid Expenses
Receivables $36.28M
Other Receivables $399.0K
Total Short-Term Assets $485.0M
YoY Change -34.28%
LONG-TERM ASSETS
Property, Plant & Equipment $22.23M
YoY Change -24.38%
Goodwill $125.5M
YoY Change 0.62%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.66M
YoY Change -5.64%
Total Long-Term Assets $214.5M
YoY Change -8.75%
TOTAL ASSETS
Total Short-Term Assets $485.0M
Total Long-Term Assets $214.5M
Total Assets $699.5M
YoY Change -28.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.08M
YoY Change -35.67%
Accrued Expenses $28.09M
YoY Change -7.86%
Deferred Revenue $3.263M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $73.95M
YoY Change -41.25%
LONG-TERM LIABILITIES
Long-Term Debt $551.4M
YoY Change -25.21%
Other Long-Term Liabilities $699.0K
YoY Change 70.49%
Total Long-Term Liabilities $699.0K
YoY Change 70.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $73.95M
Total Long-Term Liabilities $699.0K
Total Liabilities $639.8M
YoY Change -27.55%
SHAREHOLDERS EQUITY
Retained Earnings -$497.6M
YoY Change 6.0%
Common Stock $12.00K
YoY Change -14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $59.72M
YoY Change
Total Liabilities & Shareholders Equity $699.5M
YoY Change -28.11%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$18.29M
YoY Change -75.22%
Depreciation, Depletion And Amortization $8.114M
YoY Change 10.39%
Cash From Operating Activities $10.32M
YoY Change -42.57%
INVESTING ACTIVITIES
Capital Expenditures $2.092M
YoY Change -27.61%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$2.092M
YoY Change -52.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -204.0K
YoY Change -91.32%
NET CHANGE
Cash From Operating Activities 10.32M
Cash From Investing Activities -2.092M
Cash From Financing Activities -204.0K
Net Change In Cash 8.019M
YoY Change -28.21%
FREE CASH FLOW
Cash From Operating Activities $10.32M
Capital Expenditures $2.092M
Free Cash Flow $8.223M
YoY Change -45.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1908962
dei Entity Address Address Line1
EntityAddressAddressLine1
2165 Spring Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Long Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90806
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
603-4996
dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
SKIN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
124122158 shares
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11025000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6604000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36279000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54697000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
73443000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
91321000 usd
CY2024Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
399000 usd
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
332000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16034000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28877000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
485047000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
698252000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
7634000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14226000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14662000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16043000 usd
CY2024Q3 us-gaap Assets
Assets
699548000 usd
CY2023Q4 us-gaap Assets
Assets
929113000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
23084000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
44768000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16543000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22028000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78802000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97413000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
38153000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
109966000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
40649000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-12553000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1108000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1839000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33436000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36978000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
62164000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
69548000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21515000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-82101000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
4876000 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-418000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2277000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2270000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1948000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3479000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-73818000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1187000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17104000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-74911000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124057602 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132896626 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001818093
dei Entity Registrant Name
EntityRegistrantName
The Beauty Health Company
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
62123000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
125818000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28093000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19846000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
73948000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
115008000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12093000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9319000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1115000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
702000 usd
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
558000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3555000 usd
CY2024Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
551411000 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
738372000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
699000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2767000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
639824000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
869723000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
12000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
561059000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
541281000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3712000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3036000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-478867000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
59724000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
59390000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
699548000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
929113000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
250799000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
301170000 usd
us-gaap Cost Of Revenue
CostOfRevenue
120849000 usd
us-gaap Cost Of Revenue
CostOfRevenue
191743000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
112471000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5074000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7056000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
93707000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
102457000 usd
us-gaap Operating Expenses
OperatingExpenses
190567000 usd
us-gaap Operating Expenses
OperatingExpenses
221984000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-60617000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
14426000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
16782000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
69000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5337000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2997000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8364000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-164000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-93089000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
936000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2376000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18768000 usd
us-gaap Net Income Loss
NetIncomeLoss
-90713000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1093000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-676000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-572000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19444000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-91285000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124057602 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132896626 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123630811 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132679547 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142667209 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132679547 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
167053000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-20259000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-18291000 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
73000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
9938000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13348000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7468000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
7523000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-338000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
682000 usd
skin Payments For Asset Acquisitions
PaymentsForAssetAcquisitions
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5932000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
356000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6091000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8510000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-243000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
568197000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
358892000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
559444000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
250799000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
301170000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
250799000 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7565000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
6750000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4872000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33475000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5855000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-724000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70339000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17832000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-18291000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
358892000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523025000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
125455000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-497635000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14599000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12120000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
531000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4598000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1401000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2759000 usd
CY2024Q3 skin Syndeo Program Reserves
SyndeoProgramReserves
0 usd
CY2023Q4 skin Syndeo Program Reserves
SyndeoProgramReserves
21009000 usd
us-gaap Gross Profit
GrossProfit
109427000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27620000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30731000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
91786000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-112557000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2468000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3445000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
7949000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
10291000 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2195000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2034000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3577000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1310000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
152408000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3364000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
545000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
698000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8524000 usd
CY2023Q2 us-gaap Accelerated Share Repurchase Program Adjustment
AcceleratedShareRepurchaseProgramAdjustment
-2240000 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-367000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
161842000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6636000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1047000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
63295000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
202000 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
50979000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1172000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4827000 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
124111434 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
124111434 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
122899002 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
122899002 shares
us-gaap Gross Profit
GrossProfit
129950000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16343000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
888000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-73818000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
331000 usd
CY2023Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
4828000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8185000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1093000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
89957000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
59390000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-679000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1005000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
368000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
378000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6498000 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-816000 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-816000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
69189000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7712000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
1187000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
59724000 usd
us-gaap Net Income Loss
NetIncomeLoss
-18768000 usd
us-gaap Net Income Loss
NetIncomeLoss
-90713000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
20846000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
20286000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15314000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15955000 usd
us-gaap Depreciation
Depreciation
8486000 usd
us-gaap Depreciation
Depreciation
6996000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
3321000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
1751000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2532000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3172000 usd
us-gaap Inventory Write Down
InventoryWriteDown
22704000 usd
us-gaap Inventory Write Down
InventoryWriteDown
11905000 usd
skin Inventory Obsolescence
InventoryObsolescence
0 usd
skin Inventory Obsolescence
InventoryObsolescence
18809000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5135000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2760000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2997000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8364000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
33411000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-250000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
333000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
8564000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6007000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3426000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7956000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16198000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-39501000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
50118000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
7887000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26920000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5250000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7084000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3797000 usd
skin Payments For Asset Acquisitions
PaymentsForAssetAcquisitions
18458000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29339000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
156082000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1489000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2388000 usd
skin Payment Of Accelerated Share Repurchases
PaymentOfAcceleratedShareRepurchases
0 usd
skin Payment Of Accelerated Share Repurchases
PaymentOfAcceleratedShareRepurchases
2240000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1819000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-157571000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-163841000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-292000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523025000 usd
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78802000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97413000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78802000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
97413000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
301170000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26373000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
24406000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
47070000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
66915000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
73443000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
91321000 usd
us-gaap Inventory Write Down
InventoryWriteDown
22700000 usd
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
9358000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
10458000 usd
CY2024Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
4937000 usd
CY2024Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2248000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4005000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16543000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22028000 usd
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
5404000 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
4971000 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
3486000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2344000 usd
CY2024Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3424000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
3914000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3263000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
450000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12516000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8167000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28093000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19846000 usd
CY2024Q3 us-gaap Nontrade Receivables
NontradeReceivables
3000000 usd
CY2023Q4 us-gaap Nontrade Receivables
NontradeReceivables
15000000 usd
CY2024Q3 us-gaap Loss On Contract Termination
LossOnContractTermination
8000000 usd
CY2024Q3 skin Accrued Contract Termination Costs
AccruedContractTerminationCosts
2000000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
6000000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
6000000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4000000 usd
CY2023Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
2000000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
2000000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
26587000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
19953000 usd
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
7634000 usd
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14226000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
125818000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-363000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
125455000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
153497000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
102518000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
50979000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
149392000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
87269000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
62123000 usd
CY2024Q3 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
CY2024Q3 us-gaap Debt Instrument Repurchased Face Amount
DebtInstrumentRepurchasedFaceAmount
192300000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
156100000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
33400000 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2800000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3500000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2400000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1400000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1100000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7712000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8185000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20846000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20286000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
38200000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 skin Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
124111434 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
124111434 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
122899002 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
122899002 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18291000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-73818000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18768000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-90713000 usd
CY2024Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
CY2023Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-25186000 usd
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
0 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18291000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-73818000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-43954000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-90713000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124057602 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132896626 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
123630811 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
132679547 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
19036398 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124057602 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132896626 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142667209 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
132679547 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2023Q4 skin Syndeo Program Reserves
SyndeoProgramReserves
21009000 usd
CY2024Q1 skin Syndeo Program Usage
SyndeoProgramUsage
12695000 usd
CY2024Q1 skin Syndeo Program Reserves
SyndeoProgramReserves
8314000 usd
CY2024Q2 skin Syndeo Program Usage
SyndeoProgramUsage
7402000 usd
CY2024Q2 skin Syndeo Program Reserves
SyndeoProgramReserves
912000 usd
CY2024Q3 skin Syndeo Program Usage
SyndeoProgramUsage
912000 usd
CY2024Q3 skin Syndeo Program Reserves
SyndeoProgramReserves
0 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-047310-index-headers.html Edgar Link pending
0001628280-24-047310-index.html Edgar Link pending
0001628280-24-047310.txt Edgar Link pending
0001628280-24-047310-xbrl.zip Edgar Link pending
ex311-2024q310q.htm Edgar Link pending
ex312-2024q310q.htm Edgar Link pending
ex321-2024q310q.htm Edgar Link pending
ex322-2024q310q.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skin-20240930.htm Edgar Link pending
skin-20240930.xsd Edgar Link pending
skin-20240930_cal.xml Edgar Link unprocessable
skin-20240930_def.xml Edgar Link unprocessable
skin-20240930_lab.xml Edgar Link unprocessable
skin-20240930_pre.xml Edgar Link unprocessable
skin-20240930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable